首页 > 最新文献

Samj South African Medical Journal最新文献

英文 中文
Vaccines in the fight against antimicrobial resistance - perspectives from South Africa. 疫苗在抗菌药耐药性斗争中的作用--南非的观点。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i9.2111
A Brink, A Kgasi, A Musyoki, B Kagina, C Feldman, D Reddy, E Du Toit, E Kalanxhi, J Meyer, I Impalli, M Schönfeldt, M Sibanda, N Schellack, P Skosana, S Essack, S Dlamini, Y Ramsamy

Antimicrobial resistance (AMR), in which microbes adapt to and resist current therapies, is a well-recognised global problem that threatens to reverse gains made by modern medicine in the last decades. AMR is a complex issue; however, at its core, it is driven by the overuse and inappropriate use of antimicrobials. Socioeconomic factors have been identified as significant contributors to the emergence and exacerbation of AMR, especially in populations facing inadequate access to healthcare, poor sanitation services and high morbidity and mortality rates. Weak healthcare systems and water, sanitation and hygiene have been highlighted as fundamental risk factors for AMR emergence and transmission. Behavioural factors, such as purchasing antibiotics without a prescription from a registered healthcare professional, not completing the prescribed course or overly prolonged courses of antibiotics, using antibiotics to treat viral infections, lack of access to quality antibiotics, and the proliferation of substandard or falsified (SF) drugs, have also been identified as significant contributors to AMR. Low- and middle-income countries have a higher incidence of antibiotics being dispensed without a prescription than higher-income countries.

抗菌药耐药性(AMR)是微生物适应和抵制当前疗法的一种公认的全球性问题,有可能使现代医学在过去几十年中取得的成果付之东流。AMR 是一个复杂的问题,但其核心是抗菌药物的过度使用和不当使用。社会经济因素已被确定为导致 AMR 出现和恶化的重要因素,尤其是在医疗服务不足、卫生服务差、发病率和死亡率高的人群中。薄弱的医疗保健系统以及水、环境卫生和个人卫生已被强调为导致 AMR 出现和传播的基本风险因素。行为因素也被认为是导致 AMR 的重要原因,例如在没有注册医疗保健专业人员处方的情况下购买抗生素、未完成规定疗程或疗程过长、使用抗生素治疗病毒感染、无法获得优质抗生素以及劣质或伪造(SF)药物泛滥。与高收入国家相比,中低收入国家在没有处方的情况下配发抗生素的发生率更高。
{"title":"Vaccines in the fight against antimicrobial resistance - perspectives from South Africa.","authors":"A Brink, A Kgasi, A Musyoki, B Kagina, C Feldman, D Reddy, E Du Toit, E Kalanxhi, J Meyer, I Impalli, M Schönfeldt, M Sibanda, N Schellack, P Skosana, S Essack, S Dlamini, Y Ramsamy","doi":"10.7196/SAMJ.2024.v114i9.2111","DOIUrl":"10.7196/SAMJ.2024.v114i9.2111","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR), in which microbes adapt to and resist current therapies, is a well-recognised global problem that threatens to reverse gains made by modern medicine in the last decades. AMR is a complex issue; however, at its core, it is driven by the overuse and inappropriate use of antimicrobials. Socioeconomic factors have been identified as significant contributors to the emergence and exacerbation of AMR, especially in populations facing inadequate access to healthcare, poor sanitation services and high morbidity and mortality rates. Weak healthcare systems and water, sanitation and hygiene have been highlighted as fundamental risk factors for AMR emergence and transmission. Behavioural factors, such as purchasing antibiotics without a prescription from a registered healthcare professional, not completing the prescribed course or overly prolonged courses of antibiotics, using antibiotics to treat viral infections, lack of access to quality antibiotics, and the proliferation of substandard or falsified (SF) drugs, have also been identified as significant contributors to AMR. Low- and middle-income countries have a higher incidence of antibiotics being dispensed without a prescription than higher-income countries.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e2111"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicine and the Law. 医学与法律
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i9.1983
S Abdool Karim

On 15 May 2024, the National Health Insurance Act No. 20 of 2023 (the Act) was signed into law, and South Africa (SA) officially adopted a national health insurance (NHI) system as part of its efforts to achieve universal healthcare across the country. While NHI has been controversial and much talked about, plenty of how the scheme will operate remains an unknown, and has not been defined within the Act. However, it is evident that, with SA's limited healthcare budget, the NHI scheme is not going to cover everything for everyone. Some decisions will need to be made about what kinds of healthcare and other benefits South Africans can expect to have covered by the scheme - in other words, decisions about what will be included under NHI and what will be excluded. This paper does not aim to discuss the constitutionality or legality of the NHI Act, but focuses only on the issue of how government ought to consider making decisions about what services the NHI covers.

2024 年 5 月 15 日,《国家健康保险法》(2023 年第 20 号)(以下简称 "该法")签署成为法律,南非(SA)正式采用国家健康保险(NHI)制度,作为在全国范围内实现全民医疗保健的努力的一部分。虽然 NHI 一直备受争议和热议,但该计划将如何运作仍是一个未知数,而且该法案中也没有对其进行定义。不过,很明显,由于南澳大利亚的医疗预算有限,国家医疗保险计划不可能覆盖所有人的所有医疗费用。我们需要做出一些决定,确定南非人可以期待该计划涵盖哪些类型的医疗保健和其他福利--换句话说,决定哪些福利将被纳入国家健康保险,哪些福利将被排除在外。本文无意讨论《国家医疗保险法》的合宪性或合法性,而只关注政府应如何考虑就国家医疗保险涵盖哪些服务做出决定这一问题。
{"title":"Medicine and the Law.","authors":"S Abdool Karim","doi":"10.7196/SAMJ.2024.v114i9.1983","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i9.1983","url":null,"abstract":"<p><p>On 15 May 2024, the National Health Insurance Act No. 20 of 2023 (the Act) was signed into law, and South Africa (SA) officially adopted a national health insurance (NHI) system as part of its efforts to achieve universal healthcare across the country. While NHI has been controversial and much talked about, plenty of how the scheme will operate remains an unknown, and has not been defined within the Act. However, it is evident that, with SA's limited healthcare budget, the NHI scheme is not going to cover everything for everyone. Some decisions will need to be made about what kinds of healthcare and other benefits South Africans can expect to have covered by the scheme - in other words, decisions about what will be included under NHI and what will be excluded. This paper does not aim to discuss the constitutionality or legality of the NHI Act, but focuses only on the issue of how government ought to consider making decisions about what services the NHI covers.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e1893"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between tobacco and alcohol use and health outcomes in individuals living with diabetes and prediabetes in South Africa: A cross-sectional study. 南非糖尿病和糖尿病前期患者吸烟和饮酒与健康结果之间的关系:一项横断面研究。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i9.1979
S J Mulder, T Chivese, C O Egbe

Background: Smoking and alcohol misuse are lifestyle factors that can be controlled and have significant health effects. Both these factors increase the risk of developing conditions such as diabetes mellitus because they affect glucose metabolism and can interfere with blood glucose control in individuals with diabetes. Research on tobacco and alcohol use and specific health outcomes among adults with prediabetes or type 2 diabetes mellitus (T2DM) could provide valuable information leading to more efficient treatment and management of this disease.

Objectives: To assess the association between tobacco and alcohol use and specific health outcomes among South African adults with prediabetes or T2DM.

Methods: Data from the 2016 South African Demographic and Health Survey were analysed using Stata v17. Participants were classified into prediabetes or T2DM groups, based on a glycated haemoglobin cut-off of 5.7% or self-report of a previous diagnosis of T2DM. Exposures of interest were self-reported current tobacco smoking and problem/risky alcohol use. The associations between these exposures and health outcomes in the different groups were assessed using multivariable logistic regression analysis. We adjusted for specific confounders in the regression models.

Results: Of a total of 6 108 participants (mean (standard deviation) age 41 (19) years), 72.2% (n=4 409) had prediabetes and 27.8% (n=1 699) T2DM; 17.7% (n=1 084) were current smokers and 9.3% (n=565) reported problem/risky alcohol use. Current smoking was significantly associated with 40% increased odds of shortness of breath (adjusted odds ratio (aOR) 1.40; 95% confidence interval (CI) 1.1 - 1.7; p<0.001) and 67% increased odds of chronic obstructive pulmonary disease (COPD)/asthma (aOR 1.67; 95% CI 1.2 - 2.2; p<0.001). Problem/risky alcohol use was significantly associated with 40% increased odds of COPD/asthma (aOR 1.40; 95% CI 1.1 - 1.7; p=0.001) and 92% increased odds of having cancer (aOR 1.92; 95% CI 1.5 - 2.5; p<0.001).

Conclusion: There is a need for targeted smoking cessation programmes and alcohol misuse counselling among individuals living with diabetes and prediabetes.

背景:吸烟和酗酒是可以控制的生活方式因素,对健康有重大影响。这两种因素都会增加患糖尿病等疾病的风险,因为它们会影响葡萄糖代谢,并干扰糖尿病患者的血糖控制。对患有糖尿病前期或 2 型糖尿病(T2DM)的成年人进行烟草和酒精使用及特定健康结果的研究可提供有价值的信息,从而更有效地治疗和管理这种疾病:评估南非糖尿病前期或 2 型糖尿病成人中烟草和酒精使用与特定健康结果之间的关联:使用Stata v17对2016年南非人口与健康调查的数据进行分析。根据糖化血红蛋白5.7%的临界值或T2DM既往诊断的自我报告,将参与者分为糖尿病前期或T2DM组。关注的暴露因素包括自我报告的当前吸烟情况和问题/危险饮酒情况。我们使用多变量逻辑回归分析评估了不同组别中这些暴露与健康结果之间的关系。我们对回归模型中的特定混杂因素进行了调整:在总共 6 108 名参与者(平均(标准差)年龄为 41 (19) 岁)中,72.2%(n=4 409)患有糖尿病前期,27.8%(n=1 699)患有 T2DM;17.7%(n=1 084)是当前吸烟者,9.3%(n=565)报告了问题/危险饮酒。目前吸烟与呼吸急促几率增加 40% 明显相关(调整后的几率比(aOR)为 1.40;95% 置信区间(CI)为 1.1 - 1.7;p 结论:有必要为糖尿病患者和糖尿病前期患者提供有针对性的戒烟计划和酗酒咨询。
{"title":"The association between tobacco and alcohol use and health outcomes in individuals living with diabetes and prediabetes in South Africa: A cross-sectional study.","authors":"S J Mulder, T Chivese, C O Egbe","doi":"10.7196/SAMJ.2024.v114i9.1979","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i9.1979","url":null,"abstract":"<p><strong>Background: </strong>Smoking and alcohol misuse are lifestyle factors that can be controlled and have significant health effects. Both these factors increase the risk of developing conditions such as diabetes mellitus because they affect glucose metabolism and can interfere with blood glucose control in individuals with diabetes. Research on tobacco and alcohol use and specific health outcomes among adults with prediabetes or type 2 diabetes mellitus (T2DM) could provide valuable information leading to more efficient treatment and management of this disease.</p><p><strong>Objectives: </strong>To assess the association between tobacco and alcohol use and specific health outcomes among South African adults with prediabetes or T2DM.</p><p><strong>Methods: </strong>Data from the 2016 South African Demographic and Health Survey were analysed using Stata v17. Participants were classified into prediabetes or T2DM groups, based on a glycated haemoglobin cut-off of 5.7% or self-report of a previous diagnosis of T2DM. Exposures of interest were self-reported current tobacco smoking and problem/risky alcohol use. The associations between these exposures and health outcomes in the different groups were assessed using multivariable logistic regression analysis. We adjusted for specific confounders in the regression models.</p><p><strong>Results: </strong>Of a total of 6 108 participants (mean (standard deviation) age 41 (19) years), 72.2% (n=4 409) had prediabetes and 27.8% (n=1 699) T2DM; 17.7% (n=1 084) were current smokers and 9.3% (n=565) reported problem/risky alcohol use. Current smoking was significantly associated with 40% increased odds of shortness of breath (adjusted odds ratio (aOR) 1.40; 95% confidence interval (CI) 1.1 - 1.7; p<0.001) and 67% increased odds of chronic obstructive pulmonary disease (COPD)/asthma (aOR 1.67; 95% CI 1.2 - 2.2; p<0.001). Problem/risky alcohol use was significantly associated with 40% increased odds of COPD/asthma (aOR 1.40; 95% CI 1.1 - 1.7; p=0.001) and 92% increased odds of having cancer (aOR 1.92; 95% CI 1.5 - 2.5; p<0.001).</p><p><strong>Conclusion: </strong>There is a need for targeted smoking cessation programmes and alcohol misuse counselling among individuals living with diabetes and prediabetes.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e1979"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative interdisciplinary emergency neurology rotation: Building bridges for enhanced patient care. 创新性跨学科急诊神经科轮转:为加强患者护理搭建桥梁。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i9.2405
S Lahri, N Schrueder, J Carr
{"title":"Innovative interdisciplinary emergency neurology rotation: Building bridges for enhanced patient care.","authors":"S Lahri, N Schrueder, J Carr","doi":"10.7196/SAMJ.2024.v114i9.2405","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i9.2405","url":null,"abstract":"","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e2405"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary non-tuberculous mycobacteria and Mycobacterium tuberculosis complex co-infection: A pragmatic approach to its diagnosis and management in South Africa. 肺非结核分枝杆菌和复合结核分枝杆菌合并感染:南非的实用诊断和管理方法。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i9.2313
C Opperman, S Singh, Y Ghebrekristos, R Warren, W Goosen
{"title":"Pulmonary non-tuberculous mycobacteria and Mycobacterium tuberculosis complex co-infection: A pragmatic approach to its diagnosis and management in South Africa.","authors":"C Opperman, S Singh, Y Ghebrekristos, R Warren, W Goosen","doi":"10.7196/SAMJ.2024.v114i9.2313","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i9.2313","url":null,"abstract":"","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e2313"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs. 南非风湿病和关节炎协会 2024 年生物制剂和靶向合成改变病情抗风湿药物使用指南。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-02 DOI: 10.7196/SAMJ.2024.v114i10.2599
E Van Duuren, J Potts, U Brijlal, S Botha, S Didi, K Makan, M Van Dam, K Chinniah, B Hodkinson

Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) target a specific pathway of the immune system, and are usually prescribed after failure of conventional synthetic disease-modifying antirheumatic drug therapy. The choice of b/tsDMARD depends on the disease profile and comorbidities, patient preference, registered indications of the drugs, and risks associated with therapy. It is recommended that b/tsDMARDs for immune-mediated inflammatory rheumatic diseases are prescribed by a rheumatologist, and all patients must be included in the South African Rheumatism and Arthritis Association biologic registry. Knowledge of and vigilance for adverse events, particularly infections, associated with b/ts DMARD therapies are of paramount importance.

生物和靶向合成修饰性抗风湿药物(b/tsDMARDs)以免疫系统的特定途径为靶点,通常在常规合成修饰性抗风湿药物治疗失败后使用。b/tsDMARD 的选择取决于疾病概况和合并症、患者的偏好、药物的注册适应症以及治疗的相关风险。建议由风湿免疫科医生开具治疗免疫介导的炎症性风湿病的 b/tsDMARDs 处方,所有患者都必须纳入南非风湿病和关节炎协会生物制剂登记册。了解并警惕与 b/ts DMARD 治疗相关的不良事件,尤其是感染,至关重要。
{"title":"South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs.","authors":"E Van Duuren, J Potts, U Brijlal, S Botha, S Didi, K Makan, M Van Dam, K Chinniah, B Hodkinson","doi":"10.7196/SAMJ.2024.v114i10.2599","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i10.2599","url":null,"abstract":"<p><p>Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) target a specific pathway of the immune system, and are usually prescribed after failure of conventional synthetic disease-modifying antirheumatic drug therapy. The choice of b/tsDMARD depends on the disease profile and comorbidities, patient preference, registered indications of the drugs, and risks associated with therapy. It is recommended that b/tsDMARDs for immune-mediated inflammatory rheumatic diseases are prescribed by a rheumatologist, and all patients must be included in the South African Rheumatism and Arthritis Association biologic registry. Knowledge of and vigilance for adverse events, particularly infections, associated with b/ts DMARD therapies are of paramount importance.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 9","pages":"e2599"},"PeriodicalIF":1.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Ministerial Advisory Committees and 3 years of COVID-19 expertise - is the Department of Health's model for information-sharing pandemic-ready? 部级咨询委员会和 3 年的 COVID-19 专业知识--卫生部的信息共享模式是否已为大流行病做好准备?
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.7196/SAMJ.2024.v114i8.1943
M Richter, Y Nokhepheyi

Effective pandemic decision-making depends on scientific expert evidence, transparency about public health policy decision-making, its rationales and the evidence on which it is based. The South African government laudably committed its COVID-19 response to be guided by science and evidence. Yet, the expert advice that it received was not always readily made available to the public. This submission analyses the time elapsed between the submission of COVID-19 Ministerial Advisory Committees memoranda to the Minister of Health, and the Department of Health's subsequent publication of these for the period August 2020 - January 2024. It also summarises the outcomes of the Health Justice Initiative's access to information legal action against the department on expert advice and government decision-making during the pandemic.

有效的大流行病决策取决于科学的专家证据、公共卫生政策决策的透明度、其理由和所依据的证据。南非政府承诺其 COVID-19 应对措施以科学和证据为指导,这是值得称赞的。然而,政府收到的专家建议并不总是能随时向公众公布。本报告分析了从向卫生部长提交 COVID-19 部长级咨询委员会备忘录到卫生部随后公布 2020 年 8 月至 2024 年 1 月期间这些备忘录之间的时间间隔。报告还总结了 "健康正义行动"(Health Justice Initiative)就大流行病期间的专家建议和政府决策对卫生部提起的信息公开法律诉讼的结果。
{"title":"The Ministerial Advisory Committees and 3 years of COVID-19 expertise - is the Department of Health's model for information-sharing pandemic-ready?","authors":"M Richter, Y Nokhepheyi","doi":"10.7196/SAMJ.2024.v114i8.1943","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i8.1943","url":null,"abstract":"<p><p>Effective pandemic decision-making depends on scientific expert evidence, transparency about public health policy decision-making, its rationales and the evidence on which it is based. The South African government laudably committed its COVID-19 response to be guided by science and evidence. Yet, the expert advice that it received was not always readily made available to the public. This submission analyses the time elapsed between the submission of COVID-19 Ministerial Advisory Committees memoranda to the Minister of Health, and the Department of Health's subsequent publication of these for the period August 2020 - January 2024. It also summarises the outcomes of the Health Justice Initiative's access to information legal action against the department on expert advice and government decision-making during the pandemic.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 8","pages":"e1943"},"PeriodicalIF":1.5,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of hand pathology in regional orthopaedic hospitals in KwaZulu-Natal: A cross-sectional study. 夸祖鲁-纳塔尔省地区骨科医院手部病变的发病率:一项横断面研究。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.7196/SAMJ.2024.v114i8.1246
S Thabit, M O'Connor, W Parker, T Mashishi, K Moodley, A Peer, K Matanzima, A J De Villiers, O Adewusi, R Aboobaker, A Rocher

Background: Pathology of the hand causes functional impairment, with downstream effects for patient occupation, and consequently presents a socioeconomic burden. Investigation of the epidemiology of hand pathology in KwaZulu-Natal (KZN) can help reduce the burden of disease. Identifying where the greatest need is can direct patient awareness initiatives, medical training and appropriate allocation of resources.

Objectives: To establish the prevalence of hand pathology at regional hospitals that offer orthopaedic services in KZN, to describe the patients most commonly affected by these pathologies and to identify the most common pathologies.

Methods: A cross-sectional investigation of hospital records and charts of patients presenting for orthopaedic care across all 10 regional hospitals in KZN that offer orthopaedic services was undertaken for 1 week's duration (June 2022). Patients were categorised into hand pathology (HP) and general orthopaedic pathology (OP) groups, which were each subdivided into trauma and non-trauma subgroups. Demographic details were collected for all patients. For HP patients, additional detail was collected regarding diagnosis, mechanism, admission and management. The prevalence of HP was calculated as a factor of all orthopaedic presentations.

Results: During the investigation, 2 335 patients presented to orthopaedic services. HP represented 21% of these cases. The majority (17%, 406/2 335) were related to trauma and represented 23% of all the traumatic orthopaedic presentations. Distal radius (DR) fractures were the most common hand injury (46%, 188/406) and a large proportion of trauma to the bony elements of the hand were open injuries (23%, 93/406). The remainder of HP cases comprised the non-traumatic group (4%, 91/2 335) and were predominantly infections (68%, 62/91), and many patients with non-traumatic hand pathology required surgery (60%, 55/91) and admission (56%, 52/91).

Conclusion: HP represents approximately one-fifth of all orthopaedic presentations to regional health facilities in KZN offering orthopaedic care, and close to a quarter of orthopaedic trauma occurs in the hand. Based on these findings, targeted efforts to improve community awareness of precautions against trauma to the hand, osteopaenia and hand hygiene are suggested as preventive measures. Medical training should emphasise the appropriate management of DR fractures and hand infections, and resources should be differentially allocated to the management of these debilitating HPs to decrease the burden of disease.

背景:手部病变会导致功能障碍,并对患者的职业产生下游影响,从而造成社会经济负担。对夸祖鲁-纳塔尔省(KZN)手部病理学流行病学的调查有助于减轻疾病负担。确定需求最大的地区可以指导提高患者意识的举措、医疗培训和适当的资源分配:目的:在克赞纳塔尔提供骨科服务的地区医院中确定手部病变的发病率,描述最常受这些病变影响的患者,并确定最常见的病变:对克州所有10家提供骨科服务的地区医院的骨科病人的医院记录和病历进行了为期一周(2022年6月)的横向调查。患者被分为手部病理(HP)组和普通骨科病理(OP)组,每组又分为创伤和非创伤亚组。收集了所有患者的详细人口统计学资料。对于 HP 患者,还收集了有关诊断、发病机制、入院和治疗的其他详细信息。根据所有骨科病例的系数计算出 HP 的发病率:调查期间,共有 2 335 名患者到骨科就诊。HP占这些病例的21%。大多数病例(17%,406/2 335)与创伤有关,占所有创伤骨科病例的 23%。桡骨远端(DR)骨折是最常见的手部损伤(46%,188/406),大部分手部骨骼创伤为开放性损伤(23%,93/406)。其余的手外伤病例为非创伤性病例(4%,91/2 335),主要是感染(68%,62/91),许多非创伤性手部病变患者需要手术(60%,55/91)和住院治疗(56%,52/91):结论:在克州提供骨科治疗的地区医疗机构中,手部创伤约占所有骨科就诊病例的五分之一,近四分之一的骨科创伤发生在手部。基于这些发现,建议采取有针对性的预防措施,提高社区对手部创伤、骨质疏松症和手部卫生的防范意识。医疗培训应强调对DR骨折和手部感染的适当处理,并应为处理这些使人衰弱的HP分配不同的资源,以减轻疾病负担。
{"title":"The prevalence of hand pathology in regional orthopaedic hospitals in KwaZulu-Natal: A cross-sectional study.","authors":"S Thabit, M O'Connor, W Parker, T Mashishi, K Moodley, A Peer, K Matanzima, A J De Villiers, O Adewusi, R Aboobaker, A Rocher","doi":"10.7196/SAMJ.2024.v114i8.1246","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i8.1246","url":null,"abstract":"<p><strong>Background: </strong>Pathology of the hand causes functional impairment, with downstream effects for patient occupation, and consequently presents a socioeconomic burden. Investigation of the epidemiology of hand pathology in KwaZulu-Natal (KZN) can help reduce the burden of disease. Identifying where the greatest need is can direct patient awareness initiatives, medical training and appropriate allocation of resources.</p><p><strong>Objectives: </strong>To establish the prevalence of hand pathology at regional hospitals that offer orthopaedic services in KZN, to describe the patients most commonly affected by these pathologies and to identify the most common pathologies.</p><p><strong>Methods: </strong>A cross-sectional investigation of hospital records and charts of patients presenting for orthopaedic care across all 10 regional hospitals in KZN that offer orthopaedic services was undertaken for 1 week's duration (June 2022). Patients were categorised into hand pathology (HP) and general orthopaedic pathology (OP) groups, which were each subdivided into trauma and non-trauma subgroups. Demographic details were collected for all patients. For HP patients, additional detail was collected regarding diagnosis, mechanism, admission and management. The prevalence of HP was calculated as a factor of all orthopaedic presentations.</p><p><strong>Results: </strong>During the investigation, 2 335 patients presented to orthopaedic services. HP represented 21% of these cases. The majority (17%, 406/2 335) were related to trauma and represented 23% of all the traumatic orthopaedic presentations. Distal radius (DR) fractures were the most common hand injury (46%, 188/406) and a large proportion of trauma to the bony elements of the hand were open injuries (23%, 93/406). The remainder of HP cases comprised the non-traumatic group (4%, 91/2 335) and were predominantly infections (68%, 62/91), and many patients with non-traumatic hand pathology required surgery (60%, 55/91) and admission (56%, 52/91).</p><p><strong>Conclusion: </strong>HP represents approximately one-fifth of all orthopaedic presentations to regional health facilities in KZN offering orthopaedic care, and close to a quarter of orthopaedic trauma occurs in the hand. Based on these findings, targeted efforts to improve community awareness of precautions against trauma to the hand, osteopaenia and hand hygiene are suggested as preventive measures. Medical training should emphasise the appropriate management of DR fractures and hand infections, and resources should be differentially allocated to the management of these debilitating HPs to decrease the burden of disease.</p>","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 8","pages":"e1246"},"PeriodicalIF":1.5,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Registered COVID deaths in South Africa during the first year of the SARS-CoV-2 epidemic. 南非在 SARS-CoV-2 流行第一年登记的 COVID 死亡人数。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.7196/SAMJ.2024.v114i8.2269
T A Moultrie, R Dorrington, D Bradshaw, P Groenewald
{"title":"Registered COVID deaths in South Africa during the first year of the SARS-CoV-2 epidemic.","authors":"T A Moultrie, R Dorrington, D Bradshaw, P Groenewald","doi":"10.7196/SAMJ.2024.v114i8.2269","DOIUrl":"https://doi.org/10.7196/SAMJ.2024.v114i8.2269","url":null,"abstract":"","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 8","pages":"e2269"},"PeriodicalIF":1.5,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ronald Ferguson Ingle (1927 - 2022). 罗纳德-弗格森-英格尔(1927 - 2022)。
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.7196/
J Hugo, M Teichler, C Ellis, A Olivier
{"title":"Ronald Ferguson Ingle (1927 - 2022).","authors":"J Hugo, M Teichler, C Ellis, A Olivier","doi":"10.7196/","DOIUrl":"10.7196/","url":null,"abstract":"","PeriodicalId":49576,"journal":{"name":"Samj South African Medical Journal","volume":"114 8","pages":"e2492"},"PeriodicalIF":1.5,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142592141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Samj South African Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1